Abstract. The end-systolic elastance (Ees) -the slope of the end-systolic pressure-volume relationship (ESPVR) at the end of ejection phasehas become a reliable indicator of myocardial functional state. The estimation of Ees by the original multiple-beat method is invasive, which limits its routine usage. By contrast, non-invasive single-beat estimation methods, based on the assumption of the linearity of ESPVR and the uniqueness of the normalised time-varying elastance curve E N (t) across subjects and physiology states, have been applied in a number of clinical studies. It is however known that these two assumptions have a limited validity, as ESPVR can be approximated by a linear function only locally, and E N (t) obtained from a multi-subject experiment includes a confidence interval around the mean function. Using datasets of 3 patients undergoing general anaesthesia (each containing aortic flow and pressure measurements at baseline and after introducing a vasopressor noradrenaline), we first study the sensitivity of two single-beat methods -by Sensaki et al. and by Chen et al. -to the uncertainty of E N (t). Then, we propose a minimally-invasive method based on a patient-specific biophysical modelling to estimate the whole time-varying elastance curve E model (t). We compare E model es with the two single-beat estimation methods, and the normalised varying elastance curve E N,model (t) with E N (t) from published physiological experiments.
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Introduction
The relation between ventricular pressure (P) and volume (V) at the end of ejection is described by the preload and afterload independent end-systolic pressurevolume relationship (ESPVR). The slope of ESPVR -the so-called end-systolic elastance, E es -and its volume intercept (V 0 ) allow to derive the time-varying elastance E(t) = P (t)/(V (t) − V 0 ), see Fig. 1 . Under physiological loading ranges, the E es is known to be closely related to the active properties of the myocardium [1, 13] , and is assumed to be itself preload and afterload independent, and so the ESPVR to be linear. Even though the load dependency of E es has been experimentally shown [1] , the linear approximation of ESPVR and the subsequent analysis of its derived indicators have been proven to be clinically useful for performance assessment and monitoring of failing hearts, and for studying the interaction between the heart and vasculature (e.g. by assessing the so-called ventricular-arterial coupling, V va = E es /E a , with E a being the arterial elastance [13] ). Originally, E es and ESPVR were obtained using a multiple-beat measurement technique. A linear regression was fitted on the end-systolic P-V points measured at different loading conditions (e.g. by inferior vena cava occlusion, or administration of vasopressors), during cardiac catheterisation. The associated technical issues led to a development of single-beat methods [14, 15] , which allow to estimate E es and ESPVR non-invasively [5, 7] . We hypothesised that the estimation of E es using such methods is, however, too sensitive to their parameters to obtain a reliable patient-specific result.
By calibrating a biomechanical model of heart and vasculature [2, 4] using aortic pressure and flow data, we can simulate the entire P-V loop and reproduce minimally-invasively the original multiple-beat measurement method. We aimed at comparing the E es obtained by the single-beat methods or obtained by a method based on patient-specific biophysical modelling. Furthermore, we evaluated the properties of the derived time-varying elastance after spatial-temporal normalisation [16] .
Methods

Data and models
Patients and procedures Three patients undergoing general anaesthesia (GA) for neuroradiological intervention, for whom a continuous arterial pressure and cardiac output monitoring were indicated, were included in the presented observational study, approved by the ethical committee of the Société de Réanimation de Langue Française (CE-SRLF . The data collection is described in detail in [10] . Briefly, after GA induction, a transthoracic echocardiography (TTE) was performed to obtain cardiac geometry information. A transoesophageal Doppler probe (Deltex Medical, Chichester, UK) was inserted into the oesophagus in order to continuously measure the aortic flow. During the procedure, the anaesthetist could need to raise blood pressure using intravenous administration of 5µg of noradrenaline (NOR). The neuroradiologist cannulated aorta through femoral puncture, and inserted a guidewire. A fluid-filled mechanotransducer was connected to obtain the aortic pressure waveform.
Biomechanical model of heart and vasculature The model used in this study was a combination of a biomechanical heart and Windkessel circulation models connected together to represent the cardiovascular system. The heart model was derived from a previously validated complete three-dimensional (3D) model [4] by model reduction [2] . While the entire geometry was reduced to a sphere, all the passive and active properties were kept as in the 3D model. The passive part of myocardium was modelled according to Holzapfel and Ogden [8] , and adjusted using experimental data [11] . The active contraction was based on Huxley's sliding filament theory [9] . The circulation was represented by a 2-stage Windkessel model connected in series (proximal and distal capacitances and resistances). In turning the model into patient-specific regime, see also [3, 12] , first the Windkessel model parameters were calibrated by imposing the measured aortic flow and tuning the resistance and capacitance parameters, in order to fit the simulated and measured aortic pressure. Then, geometry and passive myocardial properties were calibrated using TTE data. The timing of the electrical activation was adjusted using ECG timings (in particular, the action potential duration in line with the ST interval). Finally, the myocardial contractility was tuned to minimise the difference between the simulated and measured aortic flow and pressure. The model calibration as described above was performed in two different conditions -at baseline and at maximal effect of NOR -to explore comparatively the cardiovascular effect of NOR. Data processing and signal analysis were performed in Matlab, (Natick, Massachussets, USA) in which the model [2] was implemented into a library named CardiacLab.
Single-beat estimation of E es
Method by Senzaki et al. [14] The method is based on the characteristics of the time-varying elastance E(t) described in detail by Suga et al. [16] . In brief, the normalised E(t) -with respect to the time at end-systole (t max ) and maximal elastance value (E es ), i.e. E N (t) =
E(t/tmax) Ees
-was found to be consistent across subjects and across varying loading conditions [16] . This principle therefore allows to identify a particular time-point on the subject and physiology independent "universal" E N (t), if the ratio t tmax is known. To estimate E es , the following values need to be obtained: 1) the end of isovolumic contraction (t d ) assessed by TTE; 2) ventricular pressure at the opening of aortic valve (measured by aortic catheter); 3) ejection time (from end-diastole to end-systole) by TTE; and 4) ventricular volumes (end-diastole and end-systole), accessed by TTE. We can then apply the formula by Senzaki et al. [14] :
where
, P ed being the aortic end-diastolic pressure, P es the aortic end-systolic pressure, SV the stroke volume.
Method by Chen et al. [5] This method is derived from the original method of Senzaki by optimising the following linear regression to estimate E
EF being the ejection fraction measured by TTE as the ratio between SV and the end-diastolic volume. Finally, E N,modified d
is used in Eq. (1) to estimate E chen es . We used the methods of Senzaki and Chen to predict E es .
Estimation of E es using biomechanical heart model
Model-based E es and time-varying elastance curve estimation The original multiple-beat technique involves first a construction of ESPVR, which is given by linear regression performed on the consecutive End-Systolic PressureVolume points obtained in PV loops measured in different loading conditions. Then the slope and the intercept of the ESPVR with the volume axis represent E es and V 0 , respectively. To reproduce this procedure in silico using the calibrated patient-specific model described in Section 2.1, we modified sequentially the afterload by varying Windkessel model parameters. We obtained 5 P-V loops with varying loading conditions and identified the end-systolic pressure-volume point of every P-V loop (corresponding to the aortic valve closing). We performed a linear regression to obtain E model es and V 0 , and computed the simulated varying elastance E model (t) = P (t)/(V (t) − V 0 ) (see Fig. 1 ).
Study of the simulated time-varying elastance The simulated and normalised time-varying elastances E N,model (t) were compared with the E N (t) obtained experimentally by Suga et al. [16] . Table 1 shows the main characteristics of patients and data indicators at baseline obtained from the three patients included in the study. Sensitivity analysis of the existing methods To assess the sensitivity of the Senzaki method, we used the E N (t) curve from the study of Suga et al. [16] . We generated an interpolation of all the outliers of the curve, to be able to evaluate the effect of the error in measuring E N d on the E senzaki es estimation (see Fig. 2, left) . We can see in the right panel of Fig. 2 that the standard deviation in estimating E N d had a significant impact on the predicted E senzaki es . When considering the standard deviation in the E N (t) data, the value of E es is ranging between half and twice times the predicted value, for all 3 patients.
Results
In order to appreciate the consistency between the method of Senzaki and the method of Chen, we compared the values of E es given by the two methods at baseline and at maximum effect of NOR. The results are presented in Table 2 . Table 2 . Results of the end-systolic elastance Ees (in mmHg.ml -1 ) estimation using the method of Senzaki et al. [14] , Chen et al. [5] , and the biophysical model [2] . Method from biomechanical model For the 3 subjects, we were able to calibrate the biomechanical model and obtain the P-V loop at baseline and after the administration of NOR (see example of calibration in Fig. 3 ). estimation [14] . Left: Normalised elastance curve (reproduced from Suga et al. [16] ) and E Ventricle volume (ml) Ventricle pressure (mmHg) Fig. 3 . Example of a calibrated model. The left and the middle panels display respectively the aortic blood flow and pressure at baseline (blue) and at maximal effect of noradrenaline(orange). The simulations (bold) are calibrated using patient's measured data (dashed). The right panel displays pressure-volume loops generated using the results of the aforementioned calibrated simulations at baseline (blue) and at maximal effect of noradrenaline (orange). , we performed a sensitivity analysis with respect to the error in measuring the input parameters for the model, specifically the error in the wall thickness. The wall thickness was varied by ±50% from the measured value, and the passive and active properties of the model were calibrated accordingly. Table 3 Time normalised ( t t max ) Elastance normalised ( 4 demonstrates that the biomechanical model was able not only to estimate E es , but did provide the overall time-varying elastance curve. This example shows that the E model (t) was higher when using noradrenaline (Fig. 4 left panel) , according to the expected effect of noradrenaline (enhancement of contractility). Furthermore, when E model (t) curves were normalised as described in Sec. 2.2 (see Fig. 4 right panel) , both the time-varying elastance curves (baseline and NOR) were within the physiological ranges described by Suga et al. [16] .
Discussion
In this paper, we described a mini-invasive multi-beat method to estimate patientspecific time-varying and end-systolic elastance by using biomechanical modelling. As originally described, the E es estimation involves a multiple-beat measurement of P-V loop. For technical concerns, single-beat estimation methods were developed. These methods assume the ESPVR being linear with constant slope of E es , which is extrapolated from the end-diastolic measurement point. However, the slope of the real ESPVR is decreasing when approaching the enddiastolic point [1] , deviating the estimated E es . Our method allows to modify loading conditions in order to estimate E es around the measured end-systolic P-V point, where the linearity of ESPVR can be assumed. Furthermore, we demonstrated a very high sensitivity of the single-beat estimation method by Senzaki et al. [14] to E N d parameter. Then, we demonstrated a limited accuracy of the method by Chen et al. [5] , which introduced some phenomenological terms to the equation (1) . Indeed, no concordance with the method of Senzaki et al. [14] could have been observed, the mean values and confidence intervals for E chen es estimation falling outside the ranges of E senzaki es . The reproducibility of the results obtained in the validation studies [5, 14] is therefore questioned. To address these issues, we would have to compare our results against invasive P-V loop measurements, which were not available in our study. Despite the aforementioned limitations, we used the E senzaki es estimation as a comparator for an indirect validation of our method. We verified that our simulated E model es at least fell within the ranges of the outliers of the E senzaki es , and that the normalised time-varying elastance E N,model (t) was consistent with the E N (t) from Suga et al. [16] , in all three subjects even when varying physiology (baseline vs. administration of NOR). We remark in addition that neglecting the standard deviation of the experimentally obtained E N (t) in the single-beat estimations of E es effectively means decreasing the individuality of the considered subject. We showed, however, that the specificity of patients had a great impact on the E es estimation by these methods. Our framework -based on patient-specific biomechanical modelling -allows a more detailed personalisation. The output of the model is the actual P-V loop and the entire time-varying elastance curve -both being important when considering management of individual patients. Additionally to study the sensitivity of the E N (t) given by the the range of values in the experiments [16] , we could have also explored the sensitivity of the single-beat estimation methods to the accuracy of time measurement. Clearly, during the steepest part of the E N (t) curve, a small error on the t d measurement will have a significant impact on the E N d , and therefore on the estimation of E es . Finally, the model-derived elastance would be as well a subject of analysis of sensitivity to the parameters of the model. In this paper, we considered only an example of the uncertainty in ventricular wall thickness, see Table 3 . A thorough sensitivity analysis including other input parameters remains to be done in the future.
Our study suffers from several limitations. Indeed, while the Chen's method, allows a non-invasive estimation of E es , our presented framework involves aortic pressure measurement. This preliminary setup will be improved by the methods of transferring the peripheral arterial pressure -practically always available during GA -into the central aortic pressure [6] . Also, the E N (t) curve was reproduced manually from the study of Suga et al. [16] , involving experimental setup from dogs. In the study of Senzaki et al. [14] , the authors presented an E N (t) curve from human data. They showed an absence of variability during the pre-ejection period supporting their final results regarding the reproducibility of their method. This lack of variability is however questioned by Shishido et al. [15] . In a preliminary in silico study (data not shown), we also observed a great variability in E N (t) during the pre-ejection period. For this reason, we did not use the human data made available by Senzaki et al. [14] . We could have compared our method with the method by Shishido et al. [15] aiming at considering the patient's variability of E N d estimation, by using a bilinear interpolation of the E N (t) curve. The comparison with our modelling framework will be explored in the future.
Conclusion
By using a patient-specific modelling framework, we proposed a method to estimate E es and the entire time-varying elastance curve, considering individual normalised time-varying elastance variability, at the expense of minimally invasive data measurements. This method provides patient-specific time-varying curve and estimates the value of maximum elastance. Our proposed method could be used both clinically -to assess the patients' heart function -and in cardiac modelling community to provide patient-specific input for simplified models of the heart contraction.
